DEVELOPMENT OF COVALENTLY BOUND HYALURONIC ACID AS AN ADJUVANT FOR MULTIVALENT LYME DISEASE VACCINE

NIH RePORTER · NIH · N44 · $2,999,999 · view on reporter.nih.gov ↗

Abstract

The contractor will develop a covalently attached hyaluronic acid (HyA) as a vaccine adjuvant. HyA will be developed within the context of vaccine against Borrelia to protect against Lyme Disease using the OspC antigen.

Key facts

NIH application ID: 11203936
Project number: 75N93024C00016-0-9999-1
Recipient: DESIGN-ZYME, LLC
Principal Investigator: Peter A Petillo
Activity code: N44
Funding institute: NIH
Fiscal year: 2024
Award amount: $2,999,999
Award type: —
Project period: 2024-09-30 → 2027-09-29